| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
4 companies
Bisaro Paul is a Director at MYGN with holdings across 4 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $3.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | ZTS Zoetis Inc. | Director | Buy | 2,000 | $75.88 | $151,750.00 | +7.7% | - | - | |
| Aug 16, 2021 | TXMD Therapeuticsmd, Inc. | Director | Buy | 50,000 | $0.79 | $39,500.00 | +34.0% | -21.5% | -75.4% | |
| Jun 4, 2020 | TXMD Therapeuticsmd, Inc. | Director | Buy | 50,000 | $1.14 | $57,000.00 | New | - | - | |
| Mar 12, 2019 | AMRX Amneal Pharmaceuticals, Inc. | Executive Chairman | Buy | 17,000 | $11.97 | $203,490.00 | New | - | - |